Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

910
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
910
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
Tissue Transplantation01:24

Tissue Transplantation

928
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
928
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.0K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Single Oral Coingestion of GABA and Malic Acid on Postprandial GLP-1, Glucose, and Insulin Responses in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.

Molecular nutrition & food research·2024
Same author

Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing <i>Escherichia coli</i>.

Antimicrobial agents and chemotherapy·2023
Same author

Synergistic enhancement of glucagon-like peptide-1 release by γ-aminobutyric acid and L-phenylalanine in enteroendocrine cells-searching active ingredients in a water extract of corn zein protein.

Bioscience, biotechnology, and biochemistry·2023
Same author

Tunable structure of chimeric isomaltomegalosaccharides with double α-(1 → 4)-glucosyl chains enhances the solubility of water-insoluble bioactive compounds.

Carbohydrate polymers·2023
Same author

Adverse events caused by cord blood infusion in Japan during a 5-year period.

Vox sanguinis·2022
Same author

Silica removal at sewage treatment plants causes new silica deficiency.

Scientific reports·2022
Same journal

Survival Analysis and Risk Factors of Mortality of Hemodialysis Patients With Diabetic Nephropathy: Data From the Indonesian Renal Registry.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·2026
Same journal

Corporate Members.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·2026
Same journal

The Impact of Monocyte-to-HDL Ratio and Triglyceride-Glucose Index on Arterial Stiffness in Hemodialysis Patients.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·2026
Same journal

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End-Stage Renal Disease: A Prospective Observational Study.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·2026
Same journal

Establishing an Apheresis Medicine Program in a Resource-Constrained Setting: A 5-Year Experience From Lagos, Nigeria.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·2026
Same journal

Serum Myonectin Levels Are Positively Associated With Physical Function and Lower Frailty-Related Limitation in Maintenance Hemodialysis Patients: A Cross-Sectional Study.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·2026
See all related articles

Related Experiment Videos

Allogeneic hematopoietic stem cell transplantation.

Shunro Kai1, Hiroshi Hara

  • 1The Department of Transfusion Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. Kai@hyo-med.ac.jp

Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
|August 20, 2003
PubMed
Summary
This summary is machine-generated.

Allogeneic hematopoietic stem cell transplantation using bone marrow, peripheral blood, or cord blood shows varied immune cell content, impacting recovery and graft-versus-host disease risks. Recent findings on these diverse stem cell sources are reviewed.

Related Experiment Videos

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Medicine

Background:

  • Allogeneic bone marrow transplantation has been used for over 30 years to treat hematological diseases.
  • Peripheral blood and cord blood are now also utilized as stem cell sources, expanding transplantation options.

Purpose of the Study:

  • To review recent results of allogeneic hematopoietic stem cell transplantation from diverse stem cell sources.
  • To compare the impact of different stem cell sources on transplant outcomes.

Main Methods:

  • Review of recently reported clinical results.
  • Comparative analysis of outcomes based on stem cell source (bone marrow, peripheral blood, cord blood).

Main Results:

  • Stem cell sources differ in immune cell quantity and quality.
  • Different sources lead to varied kinetics of hematological recovery.
  • Stem cell source influences the risk of graft-versus-host disease.

Conclusions:

  • The choice of stem cell source significantly impacts allogeneic hematopoietic stem cell transplantation outcomes.
  • Understanding these differences is crucial for optimizing patient treatment and minimizing complications.